Skip to main content
Clinical Trials/NCT03104049
NCT03104049
Completed
Not Applicable

Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease Patients

IRCCS San Raffaele Roma0 sites46 target enrollmentNovember 20, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
IRCCS San Raffaele Roma
Enrollment
46
Primary Endpoint
Change in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) rating scale total score between baseline evaluations and end of treatment
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Parkinson's disease (PD) is a degenerative disorder characterized by a symptom triad consisting on: tremor, rigidity and bradykinesia . To these symptoms it is often added postural alteration that can stand in two different attitudes, such as the camptocormia and the syndrome of Pisa . Progressing in its evolution, PD becomes increasingly disabling, making it difficult or even impossible daily activities such as washing or dressing.The abnormal posture, with alteration of the limbs, the neck and trunk, is a recurring feature in PD, with a frequency of about 30%. Between 2% and 12.3% are more severe abnormalities such as camptocormia, the syndrome of Pisa and the anterocollis. Several studies disease plug in Neuromuscular Taping technique (NMT) among rehabilitative tools in degenerative neurological syndromes.

To the best of our knowledge, no applications were found in PD. Therefore, the current study was designed to evaluate quantitatively the effects of the NMT intervention on the trunk kinematics during standing position. More specifically, this study aims to compare the trunk kinematic variables of patients with PD who were treated with effective NMT versus those of the subjects who received only the pharmacological treatment.

Registry
clinicaltrials.gov
Start Date
November 20, 2015
End Date
January 8, 2017
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
IRCCS San Raffaele Roma
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) rating scale total score between baseline evaluations and end of treatment

Time Frame: baseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

Secondary Outcomes

  • Change in the EuroQol 5 total score between baseline evaluations and end of treatment(baseline and end of treatment (1 month))
  • Change in the Non Motor Symptoms scale total score between baseline evaluations and end of treatment(baseline and end of treatment (1 month))
  • Change in the Freezing of Gait total score between baseline evaluations and end of treatment(baseline and end of treatment (1 month))
  • Change in the Parkinson Disease Quality of life 8 total score between baseline evaluations and end of treatment(baseline and end of treatment (1 month))

Similar Trials